文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Trends of survival in patients with multiple myeloma in Japan: a multicenter retrospective collaborative study of the Japanese Society of Myeloma.

作者信息

Ozaki S, Handa H, Saitoh T, Murakami H, Itagaki M, Asaoku H, Suzuki K, Isoda A, Matsumoto M, Sawamura M, Konishi J, Sunami K, Takezako N, Hagiwara S, Kuroda Y, Chou T, Nagura E, Shimizu K

机构信息

Department of Hematology, Tokushima Prefectural Central Hospital, Tokushima, Japan.

Department of Hematology, Gunma University, Maebashi, Japan.

出版信息

Blood Cancer J. 2015 Sep 18;5(9):e349. doi: 10.1038/bcj.2015.79.

DOI:10.1038/bcj.2015.79
PMID:26383822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4648525/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffcc/4648525/fc997fb1ad06/bcj201579f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffcc/4648525/fc997fb1ad06/bcj201579f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffcc/4648525/fc997fb1ad06/bcj201579f1.jpg

相似文献

[1]
Trends of survival in patients with multiple myeloma in Japan: a multicenter retrospective collaborative study of the Japanese Society of Myeloma.

Blood Cancer J. 2015-9-18

[2]
Survival of multiple myeloma patients aged 65-70 years in the era of novel agents and autologous stem cell transplantation. A multicenter retrospective collaborative study of the Japanese Society of Myeloma and the European Myeloma Network.

Acta Haematol. 2014

[3]
Improved survival for multiple myeloma in denmark based on autologous stem cell transplantation and novel drug therapy in collaborative trials: analysis of accrual, prognostic variables, selection bias, and clinical behavior on survival in more than 1200 patients in trials of the nordic myeloma study group.

Clin Lymphoma Myeloma Leuk. 2010-8

[4]
Response to salvage therapies and outcome in patients with multiple myeloma relapsing after pomalidomide therapy.

Leukemia. 2012-4

[5]
Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo.

Haematologica. 1999-9

[6]
[Therapeutic results and changes in prognosis in patients with multiple myeloma in central and northern Moravia over the past 40 years].

Vnitr Lek. 2002-8

[7]
Allogeneic stem cell transplantation in multiple myeloma relapsed after autograft: a multicenter retrospective study based on donor availability.

Biol Blood Marrow Transplant. 2011-8-3

[8]
Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents.

Br J Haematol. 2013-6-15

[9]
The effect of statin use at the time of autologous transplant on response and survival in multiple myeloma.

Biol Blood Marrow Transplant. 2008-3

[10]
Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.

Biol Blood Marrow Transplant. 2008-1

引用本文的文献

[1]
[Clinicobiological and prognostic profiles of multiple myeloma: about 60 cases].

Pan Afr Med J. 2025-2-3

[2]
Treatment landscape and disease burden of patients with multiple myeloma in Japan: a real-world survey.

Future Oncol. 2025-3

[3]
Characteristics and treatment patterns in patients with multiple myeloma in Japan: A retrospective cohort analysis.

PLoS One. 2025-1-23

[4]
Real-world treatment trends and triple class exposed status in newly diagnosed multiple myeloma patients in Japan: A retrospective claims database study.

PLoS One. 2024

[5]
Elranatamab in Japanese patients with relapsed/refractory multiple myeloma: results from MagnetisMM-2 and MagnetisMM-3.

Jpn J Clin Oncol. 2024-9-4

[6]
Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016-2021).

Int J Hematol. 2024-6

[7]
Treatment Pattern and Outcome of Newly Diagnosed Multiple Myeloma Patients in a Resource-Limited Setting.

Asian Pac J Cancer Prev. 2024-2-1

[8]
Molecular genetic aberrations in the pathogenesis of multiple myeloma.

Asian Biomed (Res Rev News). 2023-10-18

[9]
Survival outcomes among patients with multiple myeloma in the era of novel agents: exploratory assessment using an electronic medical record database in Japan.

PLoS One. 2023

[10]
Treatment pattern and clinical outcomes in multiple myeloma patients in Japan using the Medical Data Vision claims database.

PLoS One. 2023

本文引用的文献

[1]
Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study.

Am J Hematol. 2014-4-26

[2]
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.

Leukemia. 2013-10-25

[3]
Bortezomib-based versus nonbortezomib-based induction treatment before autologous stem-cell transplantation in patients with previously untreated multiple myeloma: a meta-analysis of phase III randomized, controlled trials.

J Clin Oncol. 2013-7-29

[4]
Multiple myeloma.

N Engl J Med. 2011-3-17

[5]
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial.

Lancet. 2010-12-3

[6]
Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study.

J Clin Oncol. 2009-12-28

[7]
Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG).

Leukemia. 2009-6

[8]
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.

N Engl J Med. 2008-8-28

[9]
Improved survival in multiple myeloma and the impact of novel therapies.

Blood. 2008-3-1

[10]
Recent major improvement in long-term survival of younger patients with multiple myeloma.

Blood. 2008-3-1

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索